Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Moodys
Medtronic
Merck

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Litigation Details for Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC (S.D.N.Y. 2012)

See Plans and Pricing

« Back to Dashboard

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC (S.D.N.Y. 2012)

Docket   Start Trial Date Filed 2012-11-07
Court District Court, S.D. New York Date Terminated
Cause 28:2201 Constitutionality of State Statute(s) Assigned To Thomas Poole Griesa
Jury Demand None Referred To Magistrate Judge Gabriel W. Go
Parties AMNEAL PHARMACEUTICALS OF NEW YORK, LLC; AMNEAL PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; GRUNENTHAL GMBH
Patents 783,337; 4,612,008; 4,765,989; 4,783,337; 4,861,598; 5,198,226; 6,488,963; 6,733,783; 7,851,482; 8,192,722; 8,309,122; 8,329,216
Attorneys Anna M Caviani Pease; Anthony C. Tridico; Basil James Lewris; Blake Greene; Carl Gismervig; Dennies Varughese; Erin Mcgeehan Sommers; Hemant Keeto Sabharwal; Jakob Benjamin Halpern; James P. Jeffry; Jennifer Howe Roscetti; Joann M. Neth; Jonathan D Loeb; Joshua Isaac Sherman; Katharine Courtney Macdonald; Krishan Thakker; Lora A. Moffatt; Martin J. Black; Oren Dov Langer; Robert D Rhoad; Sean R. Kelly; Sharon K. Gagliardi; Stephen D. Hoffman; Thomas Paul Lihan
Link to Docket External link to docket
Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC (S.D.N.Y. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-11-07 1 Complaint 1988 S‘“P‘” s,szl,sss 31 1112004 ramon "-783»337 A 11’1988 W‘.’”S‘“L 7,141,250 32 lr.'zoos onlnkeln…from U.S. Pat. Nos. 4,612,008, 4,765,989 and 4,783,337. 'l"hc disclosure of these references …the ’482 Patent. THE ’722 PATENT 33. On June 5, 2012, the PTO duly and legallyissued U.S. Patent No. 8,…Ulllt€d StateS\ Patent (10) Patent No.: US 7,851,482 BZ Dung et al. (45) Date of Patent: Dec. 14, 2010 …United States Patent (10) Patent No.: US 8,192,722 B2 Arkenau-Maric et al. (45) Date of Patent: *Jun. 5, External link to document
2015-01-15 105 AND ORDER OF INVALIDITY RE CLAIM 4 OF U.S. PATENT 7,851,482: Based on the above stipulation and with the…asserted claim 4 of the '482 patent. Endo's claim for infringement of the '482 patent (Count I of its Second…ordered as follows: 1. Asserted claim 4 of the '482 patent is hereby found and declared to be invalid. 2. …respect to Endo's claim for infringement of the '482 patent (Count I of its Second Amended Complaint), and …for a declaration of non-infringement of the '482 patent (Count 1 of its Answer, Affirmative Defenses, and External link to document
2015-03-27 122 STIPULATION AND ORDER REGARDING U.S. PATENT NO. 8,309,122 AND U.S. PATENT NO. 8,329,216: Endo and Defendants…2012 29 June 2016 1:12-cv-08115 830 Patent None District Court, S.D. New External link to document
2015-04-09 123 STIPULATION AND ORDER REGARDING U.S. PATENT NO. 8,309,122 AND U.S. PATENT NO. 8,329,216: As used in the asserted…STIPULATION AND ORDER REGARDING U.S. PATENT NO. 8,309,122 AND U.S. PATENT NO. 8,329,216" dated March 27, 2015…asserted claims of U.S. Patent 8,329,216 ("the '216 patent"), the term "a release rate profile designed…2012 29 June 2016 1:12-cv-08115 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson
Moodys
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.